Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M E Davis

Showing results (11-20 of 348) with videos related to

Pageof 35
Sort By:
The Medical Journal of Australia|April 19, 2011
Laparoscopic adjustable gastric banding in patients with insulin-treated type 2 diabetesTimothy M E Davis, Catherine Coleman
Idrugs : the Investigational Drugs Journal|October 29, 2005
TesaglitazarNiklaus Kamber, Timothy M E Davis
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2007
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetesKatrin Schimke, Timothy M E Davis
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2017
Regarding "Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy"Sam Salman, Timothy M E Davis
BMJ Open Diabetes Research & Care|March 7, 2020
Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase IITimothy M E Davis, Wendy Davis
The Medical Journal of Australia|August 4, 2010
Rosiglitazone and cardiovascular disease revisitedTimothy M E Davis, Johannes B Prins
Diabetes Care|January 30, 2007
An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis
The New England Journal of Medicine|September 11, 2004
Obesity and the metabolic syndrome in children and adolescentsTimothy M E Davis, Choo Keng Ee
Internal Medicine Journal|July 25, 2022
The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase ITimothy M E Davis, Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association|February 18, 2026
Refining insights on type 2 diabetes and aortic valve replacement-reply to Liu et alTimothy M E Davis, Wendy A Davis
Pageof 35

Showing results (11-20 of 348) with videos related to

Sort By:
Pageof 35
The Medical Journal of Australia|April 19, 2011
Laparoscopic adjustable gastric banding in patients with insulin-treated type 2 diabetesTimothy M E Davis, Catherine Coleman
Idrugs : the Investigational Drugs Journal|October 29, 2005
TesaglitazarNiklaus Kamber, Timothy M E Davis
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2007
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetesKatrin Schimke, Timothy M E Davis
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2017
Regarding "Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy"Sam Salman, Timothy M E Davis
BMJ Open Diabetes Research & Care|March 7, 2020
Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase IITimothy M E Davis, Wendy Davis
The Medical Journal of Australia|August 4, 2010
Rosiglitazone and cardiovascular disease revisitedTimothy M E Davis, Johannes B Prins
Diabetes Care|January 30, 2007
An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis
The New England Journal of Medicine|September 11, 2004
Obesity and the metabolic syndrome in children and adolescentsTimothy M E Davis, Choo Keng Ee
Internal Medicine Journal|July 25, 2022
The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase ITimothy M E Davis, Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association|February 18, 2026
Refining insights on type 2 diabetes and aortic valve replacement-reply to Liu et alTimothy M E Davis, Wendy A Davis
Pageof 35